RxDoctor Payments Data

Paulette Cazares

Psychiatry · San Diego, CANPI 1710927470

Payments from drug & device makers

$323,358in general payments, 2019–2025

Across 67 payments — averaging $4826.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$279K
  • Novo Nordisk AS$39K
  • UCB SA$4K
  • Eisai Inc.$2K
  • Livanova USA, Inc.$60
  • Intuitive Surgical$38
$10,171in research payments, 2019–2025

Across 2 payments — averaging $5085.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$10K

What the payments were for

  • Travel & lodging$1,02354%
  • Food & beverage$87146%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly10$279,423
Novo Nordisk AS34$38,542
UCB SA1$3,500
Eisai Inc.20$1,795
Livanova USA, Inc.1$60
Intuitive Surgical1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$323,358 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →